News & Analysis as of

Pharmaceutical Industry Food and Drug Administration (FDA) Legislative Committees

Foley & Lardner LLP

Health Care Policy Newsletter - June 2018

Foley & Lardner LLP on

Foley’s Bipartisan Public Policy Team is pleased to share our “Public Policy Health Care Newsletter” in which we compile the latest health care policy news and legislation. *Please note that we publish this newsletter only...more

McGuireWoods LLP

Republican HELP Committee Members Request FDA to Step Up Finalizing Biosimilars Guidances and Transparency

McGuireWoods LLP on

On April 30, 2015, Senators on the Health Education Labor and Pensions Committee (HELP) urged FDA to provide additional guidance on “important issues relating to the review and approval of license applications for biosimilar...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide